PB2144: PEARL: A STUDY TO ASSESS THE EFFICACY AND SAFETY OF PENPULIMAB PLUS LENALIDOMIDE, RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000851408.09459.79 |
| _version_ | 1797287983506784256 |
|---|---|
| author | X. Wei L. Wang J. Liang H. Shen J. Li |
| author_facet | X. Wei L. Wang J. Liang H. Shen J. Li |
| author_sort | X. Wei |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:42:43Z |
| format | Article |
| id | doaj.art-a891f83d8b044475826c6354eee6aa21 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:42:43Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-a891f83d8b044475826c6354eee6aa212024-03-02T03:29:16ZengWileyHemaSphere2572-92412022-06-0162015201610.1097/01.HS9.0000851408.09459.79202206003-02015PB2144: PEARL: A STUDY TO ASSESS THE EFFICACY AND SAFETY OF PENPULIMAB PLUS LENALIDOMIDE, RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMAX. Wei0L. Wang1J. Liang2H. Shen3J. Li41 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China1 Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Chinahttp://journals.lww.com/10.1097/01.HS9.0000851408.09459.79 |
| spellingShingle | X. Wei L. Wang J. Liang H. Shen J. Li PB2144: PEARL: A STUDY TO ASSESS THE EFFICACY AND SAFETY OF PENPULIMAB PLUS LENALIDOMIDE, RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA HemaSphere |
| title | PB2144: PEARL: A STUDY TO ASSESS THE EFFICACY AND SAFETY OF PENPULIMAB PLUS LENALIDOMIDE, RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title_full | PB2144: PEARL: A STUDY TO ASSESS THE EFFICACY AND SAFETY OF PENPULIMAB PLUS LENALIDOMIDE, RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title_fullStr | PB2144: PEARL: A STUDY TO ASSESS THE EFFICACY AND SAFETY OF PENPULIMAB PLUS LENALIDOMIDE, RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title_full_unstemmed | PB2144: PEARL: A STUDY TO ASSESS THE EFFICACY AND SAFETY OF PENPULIMAB PLUS LENALIDOMIDE, RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title_short | PB2144: PEARL: A STUDY TO ASSESS THE EFFICACY AND SAFETY OF PENPULIMAB PLUS LENALIDOMIDE, RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title_sort | pb2144 pearl a study to assess the efficacy and safety of penpulimab plus lenalidomide rituximab gemcitabine and oxaliplatin in patients with relapsed refractory diffuse large b cell lymphoma |
| url | http://journals.lww.com/10.1097/01.HS9.0000851408.09459.79 |
| work_keys_str_mv | AT xwei pb2144pearlastudytoassesstheefficacyandsafetyofpenpulimabpluslenalidomiderituximabgemcitabineandoxaliplatininpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT lwang pb2144pearlastudytoassesstheefficacyandsafetyofpenpulimabpluslenalidomiderituximabgemcitabineandoxaliplatininpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT jliang pb2144pearlastudytoassesstheefficacyandsafetyofpenpulimabpluslenalidomiderituximabgemcitabineandoxaliplatininpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT hshen pb2144pearlastudytoassesstheefficacyandsafetyofpenpulimabpluslenalidomiderituximabgemcitabineandoxaliplatininpatientswithrelapsedrefractorydiffuselargebcelllymphoma AT jli pb2144pearlastudytoassesstheefficacyandsafetyofpenpulimabpluslenalidomiderituximabgemcitabineandoxaliplatininpatientswithrelapsedrefractorydiffuselargebcelllymphoma |